QRG Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

QRG Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$597K	Buy	41,233 +2,909	+8%	+$39.2K	﹤0.01%	805
2026 Q1	$531K	Buy	38,324 +4,821	+14%	+$67.1K	0.01%	762
2025 Q4	$470K	Buy	33,503 +1,235	+4%	+$17.3K	0.01%	778
2025 Q3	$451K	Sell	32,268 -17,106	-35%	-$246K	0.01%	758
2025 Q2	$742K	Buy	49,374 +5,350	+12%	+$76.4K	0.01%	691
2025 Q1	$581K	Sell	44,024 -1,259	-3%	-$17.4K	0.01%	716
2024 Q4	$715K	Sell	45,283 -1,987	-4%	-$29.9K	0.01%	673
2024 Q3	$751K	Buy	47,270 +7,720	+20%	+$124K	0.01%	663
2024 Q2	$603K	Buy	39,550 +900	+2%	+$12.9K	0.01%	678
2024 Q1	$567K	Sell	38,650 -4,080	-10%	-$59.6K	0.01%	707
2023 Q4	$595K	Buy	42,730 +13,320	+45%	+$178K	0.01%	668
2023 Q3	$393K	Buy	+29,410	New	+$398K	0.01%	734

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

QRG Capital Management's RDY Position: Q2 2026 in Review

QRG Capital Management increased its Dr. Reddy's Laboratories (RDY) stake by 7.6% in Q2 2026, buying an estimated $39.2K and bringing the position to 41,233 shares worth $597K. The position accounts for ﹤0.01% of the portfolio, ranked #805.

QRG Capital Management first reported a position in RDY in Q3 2023 and has held it in 12 quarters since. The position peaked at $751K in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

QRG Capital Management held 41,233 shares of Dr. Reddy's Laboratories worth $597K as of Q2 2026.
QRG Capital Management bought 2,909 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $39.2K.
Dr. Reddy's Laboratories made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #805 holding.
QRG Capital Management first reported a position in Dr. Reddy's Laboratories in Q3 2023 and has held it in 12 quarters since.
QRG Capital Management's Dr. Reddy's Laboratories position peaked at $751K in Q3 2024.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.